Skip to content
Naoto T Ueno, MD, PhD· @teamoncology · X·· 2026-04-18Score60
Body

Will China only data be acceptable for FDA? That is a concern per Dr Pazdur. “We need multiregional trial.” #AACR26

Heat 2 · 1 like · 1 reply · 0 reposts

Source: Naoto T Ueno, MD, PhD · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org